RELATED PARTY TRANSACTIONS (Tables)

12 Months Ended

Mar. 31, 2026

Notes and other explanatory information [abstract]

Schedule of compensation payable

Schedule of compensation payable
Years ended March 31,		2026				2025				2024
Short-term employee benefits (salary, bonus, etc.)			4,052				13,787				2,127
Post-employment benefits
Other long-term benefits
Termination benefits			152								49
Share-based payment compensation			1,600				590
Total			5,804				1,968				2,176

Schedule of Compensation

Schedule of Compensation
Name & Principal Position		Year				Fee and Salary⁽¹⁾				Bonus				Transaction Closing Bonus⁽³⁾				Securities Under Options Granted				Shares or Units⁽¹⁶⁾				Other⁽³⁾				Total Compensation
							$				$				$				$				$				$				$
Michael Terpin
			2026				61,250				-				-				-				-				-				61,250

F. Daniel Siciliano
			2026				17,500				-				-				-				-				-				17,500

Gregory H. Bailey, M.D.⁽⁶⁾
			2026				30,000				25,000				-				-				-				-				55,000
			2025				30,000				-				-				-				-				-				30,000
			2024				49,500				-				-				-				-				-				49,500

James Mellon⁽⁶⁾
			2026				30,000				25,000				-				-				-				-				55,000
			2025				30,000				-				-				-				-				-				30,000
			2024				35,242				-				-				-				-				-				35,242

Steven Mintz⁽⁸⁾
			2026				77,500				25,000				-				54,796				-				-				157,296
			2025				30,000				-				-				113,158	(5)			-				-				143,158
			2024				45,750				-				-				-				-				-				45,750

Jean-Christophe Renondin, M.D.⁽⁷⁾
			2026				30,000				25,000				-				54,796				-				-				109,796
			2025				30,000				-				-				96,992	(5)			-				-				126,992
			2024				-				-				-				-				-				-				-

Justin Stebbing, M.D. PhD⁽⁷⁾
			2026				30,000				25,000				-				64,760				-				-				119,760
			2025				30,000				-				-				121,240	(5)			-				-				151,240
			2024				-				-				-				-				-				-				-

Linda Kozick⁽⁹⁾
			2026				-				-				-				-				-				-				-
			2025				-				-				-				-				-				-				-
			2024				42,000				-				-				-				-				-				42,000

Mark Simon⁽⁹⁾
			2026				-				-				-				-				-				-				-
			2025				-				-				-				-				-				-				-
			2024				55,500				-				-				-				-				-				55,500

Robert Glassman⁽⁹⁾
			2026				-				-				-				-				-				-				-
			2025				-				-				-				-				-				-				-
			2024				45,258				-				-				-				-				-				45,258

Schedule of outstanding equity awards

Schedule of outstanding equity awards
				Option Awards																Stock Awards⁽⁶⁾
				Number of																Number of Shares or				Market Value of Shares or
				Securities Underlying								Option				Option				Units of Stock				Units of Stock
				Unexercised Options								Exercise				Expiration				That Have				That Have
Name		Grant Date		Exercisable⁽¹⁾				Unexercisable				Price				Date				Not Vested				Not Vested
Alexander Pickett⁽²⁾		3/7/2025			36,000				-				4.45				3/7/2035				-				-
		7/27/2025			45,937				-				5.73				7/27/2035				-				-

Ian B. Walters⁽³⁾		3/30/2023			15,085				-				58.40				12/14/2026				-				-
		1/19/2022			6,285				-				204.40				12/14/2026				-				-
		1/13/2021			7,550				-				355.00				12/14/2026				-				-

Andrea E. Park⁽⁴⁾		3/7/2025			28,000				-				4.45				3/7/2035				-				-
		7/27/2025			7,820				-				5.73				7/27/2035				-				-

Allan Shaw⁽⁵⁾		3/30/2023			1,761				-				58.40				9/30/2026				-				-
		1/19/2022			840				-				204.40				9/30/2026				-				-
		1/13/2021			6,550				-				355.00				9/30/2026				-				-

Robert Kramer⁽⁶⁾		3/30/2023			2,771				-				58.40				3/30/2033				-				-
		1/19/2022			1,255				-				204.40				1/19/2032				-				-
		1/13/2021			3,050				-				355.00				1/13/2031				-				-

Brian Wiley⁽⁷⁾		3/30/2023			2,386				-				58.40				11/15/2026				-				-
		1/19/2022			3,000				-				204.40				11/15/2026				-				-

Brittany Kaiser⁽⁸⁾		3/11/2026			545,315				-				1.30				5/14/2036				-				-

Enzo Villani⁽⁸⁾		3/11/2026			545,315				-				1.30				5/14/2036				-				-

Yury Mitin⁽⁸⁾		3/11/2026			545,315				-				1.30				5/14/2036				-				-

Notes

(1)

Except as set forth below, vesting of all options is subject to continued service as an employee, director and/or consultant of Alpha Compute or a subsidiary on the applicable vesting date. One fourth of the options vested or will vest on the first anniversary of the date of grant, and the remaining balance of the options vested or will vest in 36 equal monthly installments thereafter.

(2)

On December 15, 2024, Mr. Pickett was appointed as a director of the Company and our Chief Executive Officer under a consultancy agreement and served in such capacities through December 19, 2025, his resignation date. These options were awarded to Mr. Pickett for his services as a director. One fourth of the options vested immediately on grant date, and the remaining vest in three equal annual installments thereafter.

(3)

Dr. Walters served as our Chief Executive Officer and a director of the Company through December 14, 2024. Pursuant to the terms of his employment agreement, all unvested share options immediately vested on such date. Pursuant to the terms of his share option agreements, the vested share options are exercisable for two years from this date.

(4)

On September 30, 2024, Ms. Park was appointed as our Chief Financial Officer and departed the Company in October 2025. One fourth of the options vested immediately on the grant date, and the remaining vest in three equal annual installments thereafter.

(5)

Mr. Shaw served as our Chief Financial Officer through September 30, 2024. Pursuant to the terms of his share option agreements, the vested share options are exercisable for two years from such date.

(6)

The above table excludes 4,550 RSUs to Mr. Kramer granted on January 13, 2021, with a grant date value of $1,615,250, which vested on the grant date but are subject to certain restrictions and 860 RSUs granted on January 19, 2022 with a grant date value of $175,784, which vested on the grant date.

(7)

Mr. Wiley served as our Chief Business Officer through November 15, 2024. Pursuant to the terms of his employment agreement, all unvested shares immediately vested on such date. Pursuant to the terms of his share option agreement, the vested share options are exercisable for two years from such date.

(8)

On March 11, 2026, the Board authorized the grant of 545,315 share options each to Ms. Kaiser, Mr. Mitin, and Mr. Villani, which were owed pursuant to their contractor agreements upon the Company raising at least $50 million in equity financing via either private or public share offerings. These share options were formally granted on May 14, 2026.